Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lerner, SA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grapsas, I; Lerner, SA; Mobashery, S
      Conjoint molecules of cephalosporins and aminoglycosides

      ARCHIV DER PHARMAZIE
    2. Chow, JW; Kak, V; You, I; Kao, SJ; Petrin, J; Clewell, DB; Lerner, SA; Miller, GH; Shaw, KJ
      Aminoglycoside resistance genes aph(2 '')-Ib and aac(6 ')-Im detected together in strains of both Escherichia coli and Enterococcus faecium

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    3. Hinojosa, R; Nelson, EG; Lerner, SA; Redleaf, MI; Schramm, DR
      Aminoglycoside ototoxicity: A human temporal bone study

      LARYNGOSCOPE
    4. Sasian, JM; Lerner, SA; Lin, TY; Laughlin, L
      Ray and van Cittert-Zernike characterization of spatial coherence

      APPLIED OPTICS
    5. Liang, C; Descour, MR; Sasian, JM; Lerner, SA
      Multilayer-coating-induced aberrations in extreme-ultraviolet lithography optics

      APPLIED OPTICS
    6. Torres, C; Perlin, MH; Baquero, F; Lerner, DL; Lerner, SA
      High-level amikacin resistance in Pseudomonas aeruginosa associated with a3 '-phosphotransferase with high affinity for amikacin

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    7. Lerner, SA; Sasian, JM
      Use of implicitly defined optical surfaces for the design of imaging and illumination systems

      OPTICAL ENGINEERING
    8. Lerner, SA; Sasian, JM; Descour, MR
      Design approach and comparison of projection cameras for EUV lithography

      OPTICAL ENGINEERING
    9. Lerner, SA; Sasian, JM
      Optical design with parametrically defined aspheric surfaces

      APPLIED OPTICS
    10. Rybak, MJ; Abate, BJ; Kang, SL; Ruffing, MJ; Lerner, SA; Drusano, GL
      Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    11. Vakulenko, SB; Taibi-Tronche, P; Toth, M; Massova, I; Lerner, SA; Mobashery, S
      Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEMpUC19 beta-lactamase from Escherichia coli

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. SLAVIK RS; RYBAK MJ; LERNER SA
      TRIMETHOPRIM SULFAMETHOXAZOLE-INDUCED TREMOR IN A PATIENT WITH AIDS/

      The Annals of pharmacotherapy
    13. BROWN PD; LERNER SA
      COMMUNITY-ACQUIRED PNEUMONIA

      Lancet
    14. VAKULENKO SB; GERYK B; KOTRA LP; MOBASHERY S; LERNER SA
      SELECTION AND CHARACTERIZATION OF BETA-LACTAM-BETA-3-LACTAMASE INACTIVATOR-RESISTANT MUTANTS FOLLOWING PCR MUTAGENESIS OF THE TEM-1 BETA-LACTAMASE GENE

      Antimicrobial agents and chemotherapy
    15. ALANGADEN GJ; KREISWIRTH BN; AOUAD A; KHETARPAL M; IGNO FR; MOGHAZEH SL; MANAVATHU EK; LERNER SA
      MECHANISM OF RESISTANCE TO AMIKACIN AND KANAMYCIN IN MYCOBACTERIUM-TUBERCULOSIS

      Antimicrobial agents and chemotherapy
    16. BROWN PD; LERNER SA
      EMPIRICAL THERAPY FOR COMMUNITY-ACQUIRED PNEUMONIA

      Annals of internal medicine
    17. ALANGADEN GJ; LERNER SA
      THE CLINICAL USE OF FLUOROQUINOLONES FOR THE TREATMENT OF MYCOBACTERIAL DISEASES

      Clinical infectious diseases
    18. SEYMOUR JF; CUSACK JD; LERNER SA; POLLOCK RE; KEATING MJ
      CASE CONTROL STUDY OF THE ROLE OF SPLENECTOMY IN CHRONIC LYMPHOCYTIC-LEUKEMIA/

      Journal of clinical oncology
    19. CHOW JW; ZERVOS MJ; LERNER SA; THAL LA; DONABEDIAN SM; JAWORSKI DD; TSAI S; SHAW KJ; CLEWELL DB
      A NOVEL GENTAMICIN RESISTANCE GENE IN ENTEROCOCCUS

      Antimicrobial agents and chemotherapy
    20. MANAVATHU EK; VAKULENKO SB; OBEDEANU N; LERNER SA
      ISOLATION AND CHARACTERIZATION OF A SPECIES-SPECIFIC DNA-PROBE FOR THE DETECTION OF CANDIDA-KRUSEI

      Current microbiology
    21. MANAVATHU EK; ALANGADEN GJ; LERNER SA
      A COMPARATIVE-STUDY OF THE BROTH MICRO-DILUTION AND MACRO-DILUTION TECHNIQUES FOR THE DETERMINATION OF THE IN-VITRO SUSCEPTIBILITY OF ASPERGILLUS-FUMIGATUS

      Canadian journal of microbiology
    22. TAIBITRONCHE P; MASSOVA I; VAKULENKO SB; LERNER SA; MOBASHERY S
      EVIDENCE FOR STRUCTURAL ELASTICITY OF CLASS-A BETA-LACTAMASES IN THE COURSE OF CATALYTIC TURNOVER OF THE NOVEL CEPHALOSPORIN CEFEPIME

      Journal of the American Chemical Society
    23. ALANGADEN GJ; MANAVATHU EK; VAKULENKO SB; ZVONOK NM; LERNER SA
      CHARACTERIZATION OF FLUOROQUINOLONE-RESISTANT MUTANT STRAINS OF MYCOBACTERIUM-TUBERCULOSIS SELECTED IN THE LABORATORY AND ISOLATED FROM PATIENTS

      Antimicrobial agents and chemotherapy
    24. VAKULENKO SB; TOTH M; TAIBI P; MOBASHERY S; LERNER SA
      EFFECTS OF ASP-179 MUTATIONS IN TEM(PUC19) BETA-LACTAMASE ON SUSCEPTIBILITY TO BETA-LACTAMS

      Antimicrobial agents and chemotherapy
    25. BULYCHEV A; MASSOVA I; LERNER SA; MOBASHERY S
      PENEM BRL-42715 - AN EFFECTIVE INACTIVATOR FOR BETA-LACTAMASES

      Journal of the American Chemical Society
    26. IMTIAZ U; MANAVATHU EK; MOBASHERY S; LERNER SA
      REVERSAL OF CLAVULANATE RESISTANCE CONFERRED BY A SER-244 MUTANT OF TEM-1 BETA-LACTAMASE AS A RESULT OF A 2ND MUTATION (ARG TO SER AT POSITION-164) THAT ENHANCES ACTIVITY AGAINST CEFTAZIDIME

      Antimicrobial agents and chemotherapy
    27. SIREGAR JJ; LERNER SA; MOBASHERY S
      PURIFICATION AND CHARACTERIZATION OF AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE TYPE-IIA AND KINETIC COMPARISON WITH A NEW MUTANT ENZYME

      Antimicrobial agents and chemotherapy
    28. FINK MP; SNYDMAN DR; NIEDERMAN MS; LEEPER KV; JOHNSON RH; HEARD SO; WUNDERINK RG; CALDWELL JW; SCHENTAG JJ; SIAMI GA; ZAMECK RL; HAVERSTOCK DC; REINHART HH; ECHOLS RM; HELSMOORTEL C; SOJASTRZEPA D; SCHWAITZBERG S; BAREFOOT L; FEIN AM; FEINSILVER SH; ILOWITE JS; CLARE N; SCHULMAN D; JONES CB; GRIFFIN RI; WROBEL CW; BALLOW CH; AMSDEN G; MITCHELL P; BESS T; WILKINS W; BROWN RB; MCGEE W; SAFFORD MJ; LEVINE DP; LERNER SA; KRUSE JA; BANDER JJ; MCNEIL P; MUNKARAH M; SUMMER WR; DEBOISBLANC B; LEVISON ME; KORZENIOWSKI O; SIGLER A; BALDASSARRE J; WALSH P; SAMEL C; SESSLER CN; POLK RE; ISRAEL DS; TONER J; TRAUB SL; KARRAS G; TOURVILLE D; KHAN F; KARNIK A; SCHWORER PB; MOSER RJ; LAGEMAN DJ; GREENE WH; DONELAN SV; FREI L; VITALE S; PONS VG; OCTAVIO J; RUBIN LJ; BRAUN SR; HINSON JM; PRENGER S; PRYKA RD; WAINZ R; HORTON F; HAIG GM
      TREATMENT OF SEVERE PNEUMONIA IN HOSPITALIZED-PATIENTS - RESULTS OF AMULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING INTRAVENOUS CIPROFLOXACIN WITH IMIPENEM-CILASTATIN

      Antimicrobial agents and chemotherapy
    29. IMTIAZ U; MANAVATHU EK; LERNER SA; MOBASHERY S
      CRITICAL HYDROGEN-BONDING BY SERINE 235 FOR CEPHALOSPORINASE ACTIVITYOF TEM-1 BETA-LACTAMASE

      Antimicrobial agents and chemotherapy
    30. IMTIAZ U; BILLINGS E; KNOX JR; MANAVATHU EK; LERNER SA; MOBASHERY S
      INACTIVATION OF CLASS-A BETA-LACTAMASES BY CLAVULANIC ACID - THE ROLEOF ARGININE-244 IN A PROPOSED NONCONCERTED SEQUENCE OF EVENTS

      Journal of the American Chemical Society


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 23:25:43